WHO Announces High Level Review Of Its Emergency Response Capacity 27/08/2020 Svĕt Lustig Vijay The World Health Organization will establish a new high level review of the Organization’s capacity to respond todisease outbreaks in the framework of the International Health Regulations (IHR) that govern emergency response. The aim is to ensure that WHO is “as effective as possible in operations as they unfold,” announced Director-General Dr. Tedros Adhanom Ghebreyesus […] Continue reading -> Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> Protecting Africa’s Health Workers Against COVID-19 Despite Weak Health Systems, Poor Infrastructure 24/07/2020 Paul Adepoju Ibadan, Nigeria – As the number of health care worker infections continues to rise in Africa, Health Ministers are calling attention to increasing pressure on Africa’s health system – and the people running it. Lack of personal protective equipment, adequate infection prevention protocols, and burnout have led to widespread dissatisfaction among doctors in recent weeks, […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO “Open” To Hearing More Evidence About Airborne Transmission Of SARS-CoV-2 Virus 07/07/2020 Grace Ren The World Health Organization said Tuesday that it would reconsider its longtime stance that airborne transmission of the SARS-CoV-2 virus occurs only rarely – after a group of over 239 scientists published a commentary on Monday in the Journal of Clinical Infectious Diseases, urging the agency to acknowledge the greater role played by tiny virus […] Continue reading -> Don’t Sneeze In Flight: Africa Begins Long Journey To Safe Resumption Of Air Travel 03/07/2020 Paul Adepoju Ibadan, Nigeria – The first time that businessman Soji Adegbite missed his flight, he was heading to Addis Ababa, Ethiopia from Nigeria’s Murtala Muhammed International Airport located in Africa’s largest city of Lagos. “I got there just five minutes late but that was all it took to miss the flight,” he told Health Policy Watch. […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Evidence On Convalescent Plasma Therapy To Treat COVID-19 Patients Is “Very Low Quality”, Warns WHO 24/08/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher There is insufficient evidence that treating people hospitalized for COVID-19 with blood plasma from recovered patients is safe and effective – and more randomized clinical trials are thus needed, warned the World Health Organization on Monday. Evidence overall remains “inconclusive,” said WHO chief scientist Soumya Swaminathan at a WHO press conference on Monday. She spoke […] Continue reading -> “A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> Protecting Africa’s Health Workers Against COVID-19 Despite Weak Health Systems, Poor Infrastructure 24/07/2020 Paul Adepoju Ibadan, Nigeria – As the number of health care worker infections continues to rise in Africa, Health Ministers are calling attention to increasing pressure on Africa’s health system – and the people running it. Lack of personal protective equipment, adequate infection prevention protocols, and burnout have led to widespread dissatisfaction among doctors in recent weeks, […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO “Open” To Hearing More Evidence About Airborne Transmission Of SARS-CoV-2 Virus 07/07/2020 Grace Ren The World Health Organization said Tuesday that it would reconsider its longtime stance that airborne transmission of the SARS-CoV-2 virus occurs only rarely – after a group of over 239 scientists published a commentary on Monday in the Journal of Clinical Infectious Diseases, urging the agency to acknowledge the greater role played by tiny virus […] Continue reading -> Don’t Sneeze In Flight: Africa Begins Long Journey To Safe Resumption Of Air Travel 03/07/2020 Paul Adepoju Ibadan, Nigeria – The first time that businessman Soji Adegbite missed his flight, he was heading to Addis Ababa, Ethiopia from Nigeria’s Murtala Muhammed International Airport located in Africa’s largest city of Lagos. “I got there just five minutes late but that was all it took to miss the flight,” he told Health Policy Watch. […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
“A COVID-19 Vaccine Would Pay For Itself In 5-6 Days,” Says Gavi CEO Seth Berkley 10/08/2020 Fabrice Delaye/Geneva Solutions To facilitate equitable access to COVID-19 tests, treatments, and vaccines, WHO launched the COVID-19 Access Accelerator (ACT) in April. COVAX is the vaccine component of this initiative. It is led by WHO, the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI) and the Geneva-based Gavi, the Vaccine Alliance (GAVI). Heidi.news spoke with Gavi’s Executive Director, Seth […] Continue reading -> Protecting Africa’s Health Workers Against COVID-19 Despite Weak Health Systems, Poor Infrastructure 24/07/2020 Paul Adepoju Ibadan, Nigeria – As the number of health care worker infections continues to rise in Africa, Health Ministers are calling attention to increasing pressure on Africa’s health system – and the people running it. Lack of personal protective equipment, adequate infection prevention protocols, and burnout have led to widespread dissatisfaction among doctors in recent weeks, […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO “Open” To Hearing More Evidence About Airborne Transmission Of SARS-CoV-2 Virus 07/07/2020 Grace Ren The World Health Organization said Tuesday that it would reconsider its longtime stance that airborne transmission of the SARS-CoV-2 virus occurs only rarely – after a group of over 239 scientists published a commentary on Monday in the Journal of Clinical Infectious Diseases, urging the agency to acknowledge the greater role played by tiny virus […] Continue reading -> Don’t Sneeze In Flight: Africa Begins Long Journey To Safe Resumption Of Air Travel 03/07/2020 Paul Adepoju Ibadan, Nigeria – The first time that businessman Soji Adegbite missed his flight, he was heading to Addis Ababa, Ethiopia from Nigeria’s Murtala Muhammed International Airport located in Africa’s largest city of Lagos. “I got there just five minutes late but that was all it took to miss the flight,” he told Health Policy Watch. […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Protecting Africa’s Health Workers Against COVID-19 Despite Weak Health Systems, Poor Infrastructure 24/07/2020 Paul Adepoju Ibadan, Nigeria – As the number of health care worker infections continues to rise in Africa, Health Ministers are calling attention to increasing pressure on Africa’s health system – and the people running it. Lack of personal protective equipment, adequate infection prevention protocols, and burnout have led to widespread dissatisfaction among doctors in recent weeks, […] Continue reading -> Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO “Open” To Hearing More Evidence About Airborne Transmission Of SARS-CoV-2 Virus 07/07/2020 Grace Ren The World Health Organization said Tuesday that it would reconsider its longtime stance that airborne transmission of the SARS-CoV-2 virus occurs only rarely – after a group of over 239 scientists published a commentary on Monday in the Journal of Clinical Infectious Diseases, urging the agency to acknowledge the greater role played by tiny virus […] Continue reading -> Don’t Sneeze In Flight: Africa Begins Long Journey To Safe Resumption Of Air Travel 03/07/2020 Paul Adepoju Ibadan, Nigeria – The first time that businessman Soji Adegbite missed his flight, he was heading to Addis Ababa, Ethiopia from Nigeria’s Murtala Muhammed International Airport located in Africa’s largest city of Lagos. “I got there just five minutes late but that was all it took to miss the flight,” he told Health Policy Watch. […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Two More COVID-19 Vaccine Candidates Show Promise In Peer-Reviewed Clinical Trial Results 20/07/2020 Grace Ren In the largest and perhaps most robust peer-reviewed study to date, A COVID-19 vaccine candidate developed by pharma giant AstraZeneca and Oxford University has been shown to induce strong antibody and T cell responses in healthy volunteers, according to Phase 1/2 trial results published in The Lancet on Monday. Most studies so far have focused on […] Continue reading -> NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO “Open” To Hearing More Evidence About Airborne Transmission Of SARS-CoV-2 Virus 07/07/2020 Grace Ren The World Health Organization said Tuesday that it would reconsider its longtime stance that airborne transmission of the SARS-CoV-2 virus occurs only rarely – after a group of over 239 scientists published a commentary on Monday in the Journal of Clinical Infectious Diseases, urging the agency to acknowledge the greater role played by tiny virus […] Continue reading -> Don’t Sneeze In Flight: Africa Begins Long Journey To Safe Resumption Of Air Travel 03/07/2020 Paul Adepoju Ibadan, Nigeria – The first time that businessman Soji Adegbite missed his flight, he was heading to Addis Ababa, Ethiopia from Nigeria’s Murtala Muhammed International Airport located in Africa’s largest city of Lagos. “I got there just five minutes late but that was all it took to miss the flight,” he told Health Policy Watch. […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
NCD Alliance Launches New Fund With Pharma To Bolster Prevention & Treatment Of Chronic Illnesses – That Exacerbate Risks From COVD-19 14/07/2020 Svĕt Lustig Vijay On Monday, the Geneva-based NCD Alliance launched the first-ever fund to bolster the efforts of NGOs worldwide fighting chronic diseases alongside the COVID-19 pandemic with some $US 300,000 in initial seed capital. The effort is unique in that it links major pharma interests that develop and produce drugs for non-communicable diseases (NCDs) to the support […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO “Open” To Hearing More Evidence About Airborne Transmission Of SARS-CoV-2 Virus 07/07/2020 Grace Ren The World Health Organization said Tuesday that it would reconsider its longtime stance that airborne transmission of the SARS-CoV-2 virus occurs only rarely – after a group of over 239 scientists published a commentary on Monday in the Journal of Clinical Infectious Diseases, urging the agency to acknowledge the greater role played by tiny virus […] Continue reading -> Don’t Sneeze In Flight: Africa Begins Long Journey To Safe Resumption Of Air Travel 03/07/2020 Paul Adepoju Ibadan, Nigeria – The first time that businessman Soji Adegbite missed his flight, he was heading to Addis Ababa, Ethiopia from Nigeria’s Murtala Muhammed International Airport located in Africa’s largest city of Lagos. “I got there just five minutes late but that was all it took to miss the flight,” he told Health Policy Watch. […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> WHO “Open” To Hearing More Evidence About Airborne Transmission Of SARS-CoV-2 Virus 07/07/2020 Grace Ren The World Health Organization said Tuesday that it would reconsider its longtime stance that airborne transmission of the SARS-CoV-2 virus occurs only rarely – after a group of over 239 scientists published a commentary on Monday in the Journal of Clinical Infectious Diseases, urging the agency to acknowledge the greater role played by tiny virus […] Continue reading -> Don’t Sneeze In Flight: Africa Begins Long Journey To Safe Resumption Of Air Travel 03/07/2020 Paul Adepoju Ibadan, Nigeria – The first time that businessman Soji Adegbite missed his flight, he was heading to Addis Ababa, Ethiopia from Nigeria’s Murtala Muhammed International Airport located in Africa’s largest city of Lagos. “I got there just five minutes late but that was all it took to miss the flight,” he told Health Policy Watch. […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO “Open” To Hearing More Evidence About Airborne Transmission Of SARS-CoV-2 Virus 07/07/2020 Grace Ren The World Health Organization said Tuesday that it would reconsider its longtime stance that airborne transmission of the SARS-CoV-2 virus occurs only rarely – after a group of over 239 scientists published a commentary on Monday in the Journal of Clinical Infectious Diseases, urging the agency to acknowledge the greater role played by tiny virus […] Continue reading -> Don’t Sneeze In Flight: Africa Begins Long Journey To Safe Resumption Of Air Travel 03/07/2020 Paul Adepoju Ibadan, Nigeria – The first time that businessman Soji Adegbite missed his flight, he was heading to Addis Ababa, Ethiopia from Nigeria’s Murtala Muhammed International Airport located in Africa’s largest city of Lagos. “I got there just five minutes late but that was all it took to miss the flight,” he told Health Policy Watch. […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Don’t Sneeze In Flight: Africa Begins Long Journey To Safe Resumption Of Air Travel 03/07/2020 Paul Adepoju Ibadan, Nigeria – The first time that businessman Soji Adegbite missed his flight, he was heading to Addis Ababa, Ethiopia from Nigeria’s Murtala Muhammed International Airport located in Africa’s largest city of Lagos. “I got there just five minutes late but that was all it took to miss the flight,” he told Health Policy Watch. […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy